Lamotrigine
- Product NDC
- 71335-2071
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lamotrigine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA078525
- Marketing category
- ANDA
- Substance
- LAMOTRIGINE
- Current FDA listing
- Yes
Packages
| Package NDC | Description | Marketing start | Marketing end | Sample | Status |
|---|
| 71335-2071-1 | 60 TABLET in 1 BOTTLE (71335-2071-1) | 20240403 | | No | Historical |
| 71335-2071-2 | 30 TABLET in 1 BOTTLE (71335-2071-2) | 20220325 | | No | Historical |
| 71335-2071-3 | 90 TABLET in 1 BOTTLE (71335-2071-3) | 20240403 | | No | Historical |
| 71335-2071-4 | 120 TABLET in 1 BOTTLE (71335-2071-4) | 20240403 | | No | Historical |
| 71335-2071-5 | 180 TABLET in 1 BOTTLE (71335-2071-5) | 20240403 | | No | Historical |
Related DailyMed Labels
| Set ID | Title | Manufacturer | Effective date | Type | Version |
|---|
| 68a4dac2-5015-40c5-88ca-204098c3b288 | These highlights do not include all the information needed to use LAMOTRIGINE TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE TABLETS. LAMOTRIGINE tablets, for oral use Initial U.S. Approval: 1994 | Bryant Ranch Prepack | 2024-04-03 | HUMAN PRESCRIPTION DRUG LABEL | 102 |